Trial Condition(s):

Mild to Moderate Atopic Dermatitis

A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

Bayer Identifier:

1401920

ClinicalTrials.gov Identifier:

NCT00568412

EudraCT Number:

Not Available

Study Completed

Trial Purpose

To show therapeutic efficacy of Zarzenda cream compared to Elidel cream in children and adolescents with mild to moderate atopic dermatitis

Inclusion Criteria
- male and female children and adolescents (aged 2 - 17)
- mild to moderate atopic dermatitis
- patients in whom a treatment with topical corticosteroids in not recommended or possible
- wash out periods to be observed
Exclusion Criteria
- known allergy to one of the two treatments
- known immunodeficiency
- known hepatic or renal insufficiency
- acute skin infections

Trial Summary

Enrollment Goal
80
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
No
Products
Atopiclair (Zarzenda)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Klinik und Poliklinik fuer Dermatologie, Universtitaetsklinikum

Bonn, Germany, 53105

Status
Completed
 

Trial Design